It’s 20 years since I started organizing yacht charters and regattas on the Mediterranean and in the Caribbean. The business was born of and continues to sustain my great love for sailing and deep knowledge of these beautiful seas, their coasts and islands and all the wonderful things that go along with a good sailing trip. I have travelled the world, seen its great beauty, tasted delicious food and glorious wines and have loved it all.
But, after all this time and all this travel on the high seas, the first in my affections is my birthplace, Croatia. It is not because it is my place. It’s just that Croatia has it all: the coastline, the islands with their beautiful old towns and incredible architecture, the mesmerising bays, delicious food, glorious wine, fantastic yachts and, my favourite spot of all, the paradisiacal Palmizana.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CareDx Showcases Cellular Transplantation and Therapy Portfolio at TCT
CareDx, Inc.February 5, 2021 GMT
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced plans to showcase the CareDx Cellular Transplant Therapies portfolio at the Transplantation and Cellular Therapy Meeting (TCT) February 8-12, 2021.
CareDx will have four abstracts presented in poster presentations. One poster will be presented in partnership with Atara Biotherapeutics on the potential use of AlloCell for standardized pharmacokinetic assessment in a clinical trial. The other posters will highlight data on AlloHeme and AlloSeq HCT for chimerism and recurrence surveil
CareDx Announces AlloID and Exclusive Partnership with IDbyDNA
SOUTH SAN FRANCISCO, Calif. and SALT LAKE CITY, Jan. 07, 2021 Today,
CareDx, the leading partner in transplant care, and
IDbyDNA, the company revolutionizing the use of precision metagenomics, announced an exclusive partnership focused on the development of metagenomic infectious disease testing specific to transplant patients. The companies will develop and commercialize AlloID, a tailored infectious disease testing solution that identifies more than 100 pathogens and drug resistance in viruses and bacteria, specific to organ transplant donors and recipients.
Transplant recipients take immunosuppression drugs for life to reduce the risk of organ rejection – a major side effect of a dampened immune system is a high risk of infection. Clinicians are constantly balancing therapies to maintain equilibrium and prevent both organ rejection and infection. CareDx, already a leader in multi-modality solutions for trans
Published: Jan 08, 2021
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) CareDx, Inc.. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has agreed to acquire TransChart LLC, an Ohio-based provider of electronic health record software supporting the needs of US transplant centers. The transaction is expected to close in January 2021.
TransChart provides electronic medical record software to hospitals throughout the United States to care for patients who have or may need an organ transplant. TransChart builds on the CareDx digital offerings, which include Ottr transplant electronic medical record software and XynQAPI transplant quality management solutions. This acquisition will expand CareDx’s EMR coverage to over 90 centers in total.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers
CareDx, Inc.January 8, 2021 GMT
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has agreed to acquire TransChart LLC, an Ohio-based provider of electronic health record software supporting the needs of US transplant centers. The transaction is expected to close in January 2021.
TransChart provides electronic medical record software to hospitals throughout the United States to care for patients who have or may need an organ transplant. TransChart builds on the CareDx digital offerings, which include Ottr transplant electronic medical record softw